StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences cost of goods sold ($M) ($M)

Form 10-Q / 10-K (DB)

Latest, Q2 2026
1,579
Period ended Jun 30, 2026
Change on a year earlier
+5.2%
1,501 in Q2 2025
History
71 quarters
Since Q2 2008
Sources
62
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of goods sold ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,579+5.2%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 20261,445-6.2%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 20251,624+2.7%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 20251,569-0.3%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 20251,501-2.8%Form 10-Q (filed 2025-08-07) ↗
Q1 2025Mar 31, 20251,540-0.8%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 20241,581-24.4%Form 10-K (filed 2025-02-28) ↗
Q3 2024Sep 30, 20241,574+0.6%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 20241,544+7.1%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 20241,552+10.8%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 20232,090+49.7%Form 10-K (filed 2024-02-23) ↗
Q3 2023Sep 30, 20231,565+12.2%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 20231,4420.0%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 20231,401-1.6%Form 10-Q (filed 2023-05-03) ↗
Q4 2022Dec 31, 20221,396-46.9%Form 10-K (filed 2023-02-22) ↗
Q3 2022Sep 30, 20221,395+14.1%Form 10-Q (filed 2022-11-02) ↗

Cite this data

StockData. (2026). Gilead Sciences Cost of goods sold ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_cogs

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.